Letters to the Editors
Toxic shock syndrome: A dermatological emergency
Andrew W Swarbrick,
Andrew W Swarbrick
Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
Search for more papers by this author Sujith Prasad Kumarasinghe,
Sujith Prasad Kumarasinghe
Fiona Stanley Hospital, Perth, Western Australia, Australia
University of Western Australia, Perth, Western Australia, Australia
Search for more papers by this author
Andrew W Swarbrick,
Andrew W Swarbrick
Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
Search for more papers by this author Sujith Prasad Kumarasinghe,
Sujith Prasad Kumarasinghe
Fiona Stanley Hospital, Perth, Western Australia, Australia
University of Western Australia, Perth, Western Australia, Australia
Search for more papers by this author
First published: 27 September 2017
No abstract is available for this article.
References
- 1Larkin SM, Williams DN, Osterholm MT et al. Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases. Ann. Intern. Med. 1982; 96: 858–64.
- 2Gaventa S, Reingold AL, Hightower AW et al. Active surveillance for toxic shock syndrome in the United States, 1986. Rev. Infect. Dis. 1989; 11(Suppl 1): S28–34.
- 3Callahan JE, Herman A, Kappler JW et al. Stimulation of B10.BR T cells with superantigenic staphylococcal toxins. J. Immunol. 1990; 144: 2473–9.
- 4Reingold AL, Dan BB, Shands KN et al. Toxic-shock syndrome not associated with menstruation. A review of 54 cases. Lancet 1982; 1: 1–4.
- 5Barry W, Hudgins L, Donta ST et al. Intravenous immunoglobulin therapy for toxic shock syndrome. J. Am. Med. Assoc. 1992; 267: 3315–6.
